Elder Pharmaceuticals trades higher on the bourses

12 Mar 2015 Evaluate

Elder Pharmaceuticals is currently trading at Rs. 113.00, up by 0.60 points or 0.53 % from its previous closing of Rs. 112.40 on the BSE.

The scrip opened at Rs. 112.50 and has touched a high and low of Rs. 117.00 and Rs. 111.00 respectively. So far 9868 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 257.00 on 10-Apr-2014 and a 52 week low of Rs. 102.65 on 30-Dec-2014.

Last one week high and low of the scrip stood at Rs. 115.00 and Rs. 107.10 respectively. The current market cap of the company is Rs. 232.07 crore.

The promoters holding in the company stood at 27.67 % while Institutions and Non-Institutions held 25.61 % and 46.72 % respectively.

Elder Pharmaceuticals has made major pending statutory payments of TDS, Provident Fund, ESIC, Maharashtra Labour Welfare Fund (MLWF) etc to the tune of roughly Rs 26 crore. The company which was going through erratic cash flow situation since some time plans to clear the backlog of other payments very soon. The company is also in talks to raise fresh funds through a combination of debt and equity.

Elder Pharmaceuticals has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×